The Effect of Diabetes Mellitus on Retinal Function by Zvia Burgansky-Eliash
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
11 
The Effect of Diabetes Mellitus 
 on Retinal Function 
Zvia Burgansky-Eliash 
Department of Ophthalmology, The Edith Wolfson Medical Center, 
 Holon, Sackler Faculty of Medicine, Tel-Aviv University, 
 Israel 
1. Introduction 
Diabetic retinopathy (DR) is the leading cause of blindness in adults less than 70 years of age 
in the western world (Kempen, et al., 2004). It is estimated that 1 in 29 Americans 40 years 
and older has diabetic retinopathy (4.1 million persons) and 1 in 132 persons has vision-
threatening DR (Kempen et al., 2004). Diabetic retinopathy is characterized by microvascular 
changes. Despite the fact that DR is a common complication of diabetes, many cases are 
detected only at a late phase where visual acuity is impaired and some irreversible retinal 
damage has occurred (Aiello, 2003).  
Structural changes in the microvasculature during the progression of diabetic retinopathy 
are well characterized. The earliest detectable changes in diabetic retinopathy are the 
morphological appearance of microaneurisms and capillary occlusions (Apple DJ, 1985). At 
an early stage the diabetic eye loses pericytes and undergoes structural alteration in smooth 
muscle cells, as well as proliferation of endothelial cells (Ansari, et al., 1998, Paget, et al., 
1998). The loss of pericytes causes microaneurysm formation, while basement membrane 
thickening and endothelial cell proliferation lead to vascular occlusion (Dodge & D'Amore, 
1992). The challenge in ophthalmologic management of diabetic patients is to detect 
abnormalities in microvascular hemodynamics before gross morphological changes appear, 
allowing the physician to intervene in the progress of disease before the damage becomes 
irreversible  
Abnormalities detected in the retina can also provide an indication of the effect of 
systemic diseases. Standard ophthalmoscopy, however, is observer dependent, and too 
imprecise to use as a risk indicator of increased cardiovascular morbidity and mortality, 
either in diabetic (van Hecke, et al., 2006) or in hypertensive patients (van den Born, et al., 
2005). A device that automatically assesses functional changes in the retinal 
microvasculature by detecting and quantifying subtle alterations in flow velocity might 
serve to overcome the limits of standard morphological evaluation. The functional results 
obtained by such a method can also help to differentiate between diseases whose 
structural effects, albeit pronounced, may be open to ambivalent interpretation. Therefore, 
it appears that development of additional devices based on new principles to measure 
blood flow and or flow velocity is warranted.  
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Functional optical imaging of the eye represents a novel non-invasive diagnostic approach 
for the measurement of retinal blood flow-velocities, mapping of vascular network 
structure, and for obtaining information about the oximetric (Abramoff, et al., 2006, 
Grinvald, et al., 2004, Hanazono, et al., 2007) and metabolic status of the retina (Grinvald, et 
al., 1986, Nelson, et al., 2005).  
2. Blood flow velocity measurement in patients with diabetes mellitus 
The diabetic pathological processes, which initially are subtle, affect retinal hemodynamics. 
In the normal retina, autoregulated vascular responses keep the blood flow constant over a 
range of systemic blood pressures and intraocular pressures (Riva, et al., 1981, Robinson, et 
al., 1986). Vessels are controlled through local factors, (Haefliger & Anderson, 1997, Matsugi, 
et al., 1997a, atsugi, et al., 1997b, Riva et al., 1981, Shepro & Morel, 1993) which primarily 
target smooth muscle cells in arterioles and capillary pericytes (Shepro & Morel, 1993, Sims, 
1986). In patients with diabetes, however, there are changes in local vasoactive factors as 
well as in the response of pericytes to these factors (Bursell, et al., 1997, de la Rubia, et al., 
1992, Gillies & Su, 1993, Joussen, et al., 2002, King, et al., 1994, Riva et al., 1981).  
 
Fig. 1. Blood-flow velocity imaged by Retinal Function Imager in a healthy subject, the 
velocity (mm/sec) in secondary and tertiary branches of arteries (red) and veins (purple) is 
shown. 
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The flow-velocity modality of the Retinal Function Imager (RFI) identifies the motion of red 
blood cells in retinal vessels by comparing images in a short movie (8- 24 frames) of the 
retina taken under green light. Each series of 8 frames is acquired within a single short 
interval of less than 200 msec. To avoid heart-beat pulsation bias of the measured velocities, 
the timing of a series capture is always triggered on the ECG. The distance traveled by red 
blood cells in a known time is calculated for each of several retinal blood vessel segments, 
using a cross-correlation algorithm (Grinvald et al., 2004) and thus directly measuring their 
average simultaneous velocities. The measured velocity in secondary and tertiary branches 
of arterioles and venules is recorded by superimposing it on the fundus image (mm/sec; 
Figure 1).  
2.1 Blood flow velocity in patients with Diabetic retinopathy (DR)  
To study the effect of DR on the retinal blood flow velocity 42 diabetic patients (58 eyes) and 
32 healthy subjects (51 eyes) were recruited (Burgansky-Eliash, et al., 2010). All of the 
patients in that study group were suffering from adult-onset diabetic mellitus with 
moderate to severe NPDR in the study eye(s) (ETDRS categories D or E). All subjects were 
scanned using the RFI resulting in simultaneous measurement of blood-flow velocities in 
multiple macular vascular segments. In addition, information about medical history and 
smoking habits were recorded, systemic blood pressure and intraocular pressure were 
measured and heart rate recording from the RFI was obtained. 
The retinal blood flow velocity in the DR patients was significantly slower than in the 
healthy subjects. The average flow velocities (in mm/sec) of all arterial segments in an eye 
was 3.74 ± 1.09 for the diabetic patients and 4.19 ± 0.99 for the controls. The difference was 
significant (p<0.001) using model considering parameters variable between the groups 
(gender, age, systolic blood pressure, heart rate, hypertension and smoking status). The 
average velocity of all venous segments in an eye was lower than the average arterial 
velocities: 2.61 ± 0.65 in the diabetic group and 3.03 ± 0.59 in the healthy group. This 
difference was statistically different (p=0.004, table 1).  
 
 NPDR Patients 
N = 58 (eyes) 
Healthy Subjects 
N = 51 (eyes) 
P* 
Arteries 
(mm/sec, mean ± SD) 
3.74 ± 1.09 4.19 ± 0.99 <0.001 
Veins 
(mm/sec, mean ± SD) 
2.61 ± 0.65 3.03 ± 0.59 0.004 
* Mixed effect model adjusted for gender, age, systolic blood pressure, heart rate, hypertension and 
smoking status, NPDR= nonproliferative diabetic retinopathy. 
Table 1. Blood-Flow Velocity in Arteries and Veins of Diabetic Patients and Healthy Subjects 
The retinal blood-flow velocity and volume in patients with NPDR was compared to 
controls using multiple measuring devices indicating that blood-flow velocity in general is 
decreased in patients with NPDR (Arend, et al., 1995, Grunwald, et al., 1986, Hudson, et al., 
2005), whereas blood-flow volume measured at or near the level of the whole retina is not 
decreased (Grunwald et al., 1986, Hudson et al., 2005) and may even be increased (Yoshida, 
et al., 1983). With the progression of retinopathy, there is evidence showing further 
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reduction in blood flow velocity (Arend, et al., 1991, Blair, et al., 1982, Grunwald et al., 1986, 
Yoshida et al., 1983) though conflicting data exist (Hudson et al., 2005).  
Of the 58 diabetic eyes, 33 (57%) had clinically significant macular edema according to the 
ETDRS criteria (1991), and 36 (62%) had previously undergone focal laser treatment of the 
macula. When the diabetic patients were sub grouped according to the presence or absence 
of macular edema and prior macular laser treatment, differences between subgroups were 
not significant (P = 0.22 in venules 0.52 in arterioles; in the mixed-effect model, blood-flow 
velocity is compared between the subgroups taking into account the repeated measures of 
velocities in the two eyes, gender and age; table 2). These results are consistent with 
previous findings from examination of arteriole diameters (Jeppesen & Bek, 2006), from 
laser Doppler flowmetry (Guan, et al., 2006), and from SLO FA videos (Arend et al., 1995) 
but not in a more recent SLO FA study (Sakata, et al., 2006). Landa et al. found a correlation 
between RFI average blood flow velocity in retinal veins and the degree of retinal edema 
represent by OCT central retinal volume(Landa, et al., 2009). 
 
  
Diabetic Macular Edema 
No
(n = 25)
Yes 
(n = 33) 
Macular laser 
treatment 
No 
(n = 22) 
(n = 13)
A*: 4.16 ± 1.22 
V**: 2.73 ± 0.42
(n = 9) 
A: 3.27 ± 1.0 
V: 2.3 ± 0.49 
Yes 
(n = 36) 
(n = 12)
A: 3.8 ± 0.8 
V: 2.8 ± 0.71
(n = 24) 
A: 3.65 ± 1.1 
V: 2.56 ± 0.71 
*A = arteries; **V = veins  
Table 2. Effects of Macular Edema and Prior Laser Treatment on Retinal Blood Flow Velocity 
2.2 Blood flow velocity in patients with pre-retinopathy diabetes mellitus 
After confirming blood flow velocity alternation in the patients with existing DR, a study 
was performed utilizing the RFI in order to discover hemodynamic changes in patients with 
diabetes mellitus before morphological changes occur in the retina. This study compared the 
blood-flow velocity in the retinal vasculature of adult-onset diabetic mellitus patients with 
no evidence of diabetic retinopathy (23 eyes of DM patients) to that of aged-matched 
healthy controls (51 eyes of 31). Retinal blood flow velocity was measured using the RFI. 
Measurement of systemic blood pressure, intraocular pressure, blood glucose level, 
glycosylated haemoglobin (HbA1C) and body mass index (BMI) were recorded, and heart 
rate recording from the RFI was obtained. 
The average blood-flow velocity in the arteries was 4.7±1.7 mm/sec in the DM group. This 
was significantly higher than in the healthy subjects (4.1±0.9 mm/sec, p=0.03, table 2). As 
expected, in both groups venous velocity was slower than in the arteries. The DM group had 
significantly increased venous velocity compared to healthy controls (3.8±1.2 mm/sec vs. 
2.9±0.5 mm/sec, respectively; p<0.0001). In the DM group, the velocity values of either 
arteries or veins were not correlated to the duration of diabetes or the levels of glucose, 
HbA1C or BMI. 
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Early DM 
(N=23) 
Healthy 
(N=51) 
P* 
Arteries 
(mm/sec, mean ± SD) 
4.7 ± 1.7 4.1 ± 0.9 0.03 
Veins 
(mm/sec, mean ± SD) 
3.8 ± 1.2 2.9 ± 0.5 < 0.001 
* Mixed effect model adjusted for gender, age and repeated measures of velocity for both eyes of some 
patients, DM=diabetes mellitus  
Table 3. Blood-Flow Velocity in Arteries and Veins of Diabetic Patients and Healthy Subjects 
The increased velocity found in pre-retinopathy patients compared to healthy has the 
opposite direction to the findings in NPDR patients (Burgansky-Eliash et al., 2010). Thus, the 
patient/healthy blood-flow velocity relationship reverses during the development of 
morphological alterations in the retina, as arteries reach the end of their compensating 
range, or capillary resistance assumes dominance in determining flow volume. In 
longitudinal studies(Konno, et al., 1996, Rimmer, et al., 1989) decreasing blood-flow velocity 
over time was found in some but not all diabetic patients.  
Considering other causes, the increased velocity found in the DM group might reflect 
counteracted perfusion abnormalities in diabetic patient retina, stimulated, for example, by 
changes in blood rheological properties or increased vascular resistance. In diabetic patients 
there is increased aggregation and reduced deformability of red blood cells, with increased 
plasma viscosity (Burgansky-Eliash et al., 2010, McMillan, 1975, McMillan, 1978), translating 
to increased capillary resistance. Vascular resistance can result also from multiple molecular 
changes associated with long term hyperglycemia as well as endothelial dysfunction. Many 
of these pathways are interrelated and may be simultaneously activated in retinal cells 
(Schmetterer & Wolzt, 1999). Some known vasoconstrictor effectors are related to diabetic 
changes like increased expression of endothelin-1 (ET-1)(Takagi, et al., 1996), and over 
activation of protein kinase C (PKC)(Grunwald, 1996). Other vasodilatory mechanisms were 
identified as well, like ET-1 resistance, inhibition of calcium-influx channel in smooth 
muscle cells, tissue hypoxia(Gardiner, et al., 2007), and increased activity of Nitric oxide 
syntase(do Carmo, et al., 1998). In addition, in diabetes there is increased leukocytes 
adhesion to endothelium which is caused by increased expression of adhesion molecules 
(Miyamoto, et al., 1998) and is associated with endothelial dysfunction(Abiko, et al., 2003). 
Indeed, in vivo studies found elevated levels of markers of endothelial dysfunction in 
patients with diabetic retinopathy (soluble intercellular adhesion molecule-1 (sICAM-1) and 
soluble vascular cell adhesion molecule-1(sVCAM)(van Hecke, et al., 2005). However, 
studies mimicking retinal capillary obstruction by leukocytes did not detect an effect on 
retinal blood flow(Abiko et al., 2003). The most physiologically plausible scenario consistent 
with the findings reported here is that arteries widen in response to impaired capillary 
perfusion, while venous diameter remains relatively constant. An increase in the 
arterial/venous diameter ratio is implied by the finding of a greater relative increase in 
venous velocity (31%) compared to arterial velocity (15%). Excluding an increase in blood 
pressure, this also implies increased flow volume. Either excessive vasodilatation as a 
feedback to local ischemia or inhomogeneity in capillary resistance where some capillaries 
close while other dilate, could produce this over-compensation and increased flow volume. 
These changes could join a vicious cycle, according to the hemodynamic 
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hypothesis(Parving, et al., 1983, Zatz & Brenner, 1986) that increased blood flow in diabetes 
patients induces further endothelial damage due to increased shear stress(Kohner, et al., 
1995). The decreased vessel density in early diabetes that was found here, was reported 
previously(Arend et al., 1991). 
2.3 The correlation of blood flow velocity to physiological parameters  
2.3.1 Correlation to blood pressure 
In the healthy group the flow velocity in the arterioles, but not in the venules, was found to 
be positively correlated with the mean arterial pressure (r = 0.29, p = 0.006; Figure 2, systolic 
BP: r=0.3, p=0.04, diastolic BP: r=0.4, p=0.009). 
 
Fig. 2. Correlation between the blood-flow velocity imaged by the Retinal Function Imager 
and the mean arterial pressure in healthy subjects.  
However, there was no significant correlation between flow velocity and mean arterial 
pressure in the diabetic retinopathy or the pre-retinopathy cohorts. This reduced correlation 
in the diabetic group compared to the healthy group does not necessary implies that a 
fundamental dependency is lost. One possibility is that the dependency relationship itself 
changes as diabetes develops, so that statistical significance is obscured by uncontrolled 
factors between patients, such as the progress of the disease.  
2.3.2 Correlation to heart rate 
The average heart rate did not correlate with average velocity of either the healthy, the DM 
or DR groups. The relationship between retinal blood-flow-velocity and heart rate in 
individual participants was assessed by correlating the heart rate recorded by the 
instrument in parallel with each velocity measurement. For each participant we obtained a 
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series of three separate paired measurements of heart rate and flow-velocity. Each value was 
normalized by the corresponding subject's average. In healthy subjects there is a positive 
correlation between the heart rate and both arterial and venous velocity (r=0.4, p<0.0001 for 
both arteries and veins, figure 3A). In the DM patients a small correlation exists only with 
the arterial velocity and not with the venous velocity (r=0.4, p=0.0008 for arteries, r=0.06 
p=0.6 for veins, figure 3B). In the diabetic group, points showed a tendency to cluster 
around a normalized heart-rate value of 1, because in some members of this group the heart 
rate over the series was relatively stable. These patients apparently did not differ clinically 
from the rest of the diabetic retinopathy population. Overall, our diabetic patients 
demonstrated a correlation between blood-flow velocity and heart rate, although the 
relationship was less pronounced than in the healthy subjects, possibly because normalized 
heart rates in the latter group were distributed more widely. 
 
Fig. 3. Correlation between retinal blood flow-velocity and heart rate of all individual series 
data normalized by the corresponding subject average. A. Healthy group , B. Diabetes 
mellitus group, C. Diabetic retinopathy group 
These findings are consistent with derangement of autoregulatory control mechanisms in 
diabetic patients (Frederiksen, et al., 2006, Sinclair, et al., 1982), and might be an important 
characteristic of diabetic retinopathy that warrants future research. 
3. Non-invasive Capillary-Perfusion Maps (nCPM)  
The retinal function imager (RFI) incorporates a noninvasive method of imaging and 
mapping the capillaries using the intrinsic contrast chromophore, hemoglobin. Fast 
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acquisition of images at a wavelength strongly absorbed by hemoglobin enables the 
motion of RBCs to be detected, and by tracing the paths of this perfusing motion, the 
capillaries can be visualized to create non-invasive capillary-perfusion maps (nCPMs, 
figure 4). Fifty-eight eyes of 47 patients with diabetes were scanned (average age, 60.3 ± 
11.5); 38 had non-proliferative DR (NPDR) and 20 had proliferative diabetic retinopathy 
(PDR). 
 
Fig. 4. A. Non-invasive capillary perfusion map in a healthy subject B. corresponding 
fluorescein angiography (FA) image Scale bar, 500 μm. 
Vascular abnormalities seen in the nCPMs of patients with NPDR demonstrate details such 
as vascular loops and arteriovenous shunts (Figures 5A, 5B). Images of patients with NPDR 
also demonstrate areas of capillary non-perfusion (Figures. 5C, 5D).  
The nCPM images obtained by RFI scanning from eyes with PDR display 
neovascularization at the optic disc and elsewhere (Figure 6). These coarse, tortuous vessels 
can be seen protruding from the retina or optic disc surface . 
The nCPM provided good capillary perfusion maps that were comparable to the images 
acquired with an extrinsic contrast agent. Acquisition of nCPM images is non-invasive, 
comfortable and fast and can be repeated as often as clinically required.  
In 14 eyes with DR, a clear image of the fovea was available (in 2 with PDR and in 12 with 
NPDR). The mean foveal avascular zone (FAZ) diameter and area in these patients were 
641.5 ± 82.3 µm and 0.201 ± 0.07 mm2, respectively (Figure 7b). This was significantly larger 
than the corresponding values recorded above for healthy subjects (n = 37, Figure 7a; P < 
0.001 for both diameter and area). Patients with DR were older (average age, 59.2 ± 10.6) 
than the healthy subjects (average age, 34.8 ± 10.1; P < 0.001). However, the correlation 
between age and FAZ size was not significant. Good correlation was found between FAZ 
diameter and visual acuity in these patients (R2 = 0.34, P < 0.05); thus, poorer visual acuity 
was associated with larger FAZ diameter. 
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Fig. 5. Non-invasive capillary perfusion map and fluorescein angiographic (FA) images from 
patients with non-proliferative diabetic retinopathy. A. nCPM of a patient with NPDR. B. 
Corresponding FA scanning. The nCPM demonstrates vascular loops (red ellipse) and 
vascular shunts (green arrow). C. nCPM a patient with NPDR. D. Corresponding FA image; 
yellow arrows demonstrate non-perfusion.  
www.intechopen.com
 Diabetic Retinopathy 
 
216 
 
Fig. 6. Non-invasive capillary perfusion imaging of patients with proliferative diabetic 
retinopathy (PDR). A. nCPM image demonstrating neovascularization of the optic disc 
(NVD), and B. equivalent fluorescein angiography (FA) images at different stages after 
fluorescein injection. C. Another example of an nCPM image demonstrating NVD. D. nCPM 
images showing abnormal vasculature E. Corresponding FA and. F. nCPM image of 
neovascularization elsewhere (NVE). 
 
Fig. 7. Foveal avascular zone (FAZ) measurements. A) healthy subject, B) DR patient. Area 
and diameter, respectively, of FAZ: a) 0.114 mm2, 464 µm; b) 0.225 mm2, 672 µm. The green 
dotted line encircles the FAZ. Scale bar, 500 μm. 
www.intechopen.com
 The Effect of Diabetes Mellitus on Retinal Function 
 
217 
The size of the FAZ reflects the condition of the capillary circulation surrounding the foveal 
area, and can be a valuable staging tool as it increases under pathological conditions 
(Conrath, et al., 2005, Yap, et al., 1987). FAZ was measured noninvasively as long as 20 years 
ago by the entoptic method (Bradley, et al., 1992), revealing an increase in FAZ size in DR 
patients (Applegate, et al., 1997). That method, however, is subjective and depends on 
patient training and compliance. Our measurements revealed a significant increase in FAZ 
size in patients with DR relative to the healthy group. The FAZ measurement obtained by 
nCPMs in healthy subjects was within the documented range of the FAZ diameter (350–750 
µm) (Tyrberg, et al., 2008). Loss of capillaries in the fovea is common in patients with 
ischemic retinopathies, and FAZ size has been shown to correlate with the visual prognosis 
in these cases (Mintz-Hittner, et al., 1999, Tyrberg et al., 2008). As previously reported 
(Applegate et al., 1997), we found a correlation between poorer visual acuity and larger FAZ 
diameter. Thus, the use of nCPM images should make it possible to measure FAZ easily, 
and provide a convenient and safe way to monitor this zone for an increase in size and other 
related changes during follow-up. Measurement of FAZ size can also help to assess 
suitability for treatment, given that different treatments are needed for a highly ischemic 
fovea and one that is well perfused (Chung, et al., 2008). 
 
Fig. 8. Qualitative oximetric image obtained with the RFI from the retina of a healthy 
volunteer. Arteries, veins, and capillaries appear in different colors because of the different 
oxygen saturation levels of blood. 
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3. Oxymetry 
The balance of oxygen supply and demand in the retina is closely regulated to maintain the 
processes of visual perception. Alterations in either oxygen supply or consumption might 
directly indicate the early onset of retinal abnormalities. The difference between the 
absorption spectra of oxyhemoglobin and deoxyhemoglobin can be used to determine the 
oxygenation of blood with multispectral imaging methods. Evaluation of retinal oxygen 
utilization may provide essential information about metabolic state of the retina, and assist 
in early detection of retinovascular diseases. 
In multispectral imaging mode, the RFI can perform spectroscopic decomposition to 
qualitatively assess the oximetric state of the retina (Izhaky, et al., 2009). A qualitative 
oximetry map of a healthy volunteer was obtained by acquiring retinal images at two 
wavelengths (oximetric, 575 ± 5 nm, and isosbestic, 569 ± 5 nm). Differential decomposition 
analysis was used to generate the oximetry image (Figure 8). 
Quantitative retinal oximetry was studied previously in healthy subjects revealing 
reproducible results that were sensitive to changes in oxygen concentration (Hardarson, et 
al., 2006). In patients with central retinal vein occlusion, oxygen saturation in veins of the 
affected eye was lower than in the fellow eye (Hardarson & Stefansson, 2010). Retinal 
oxymetric evaluation using imaging oximeter (oxygen module by Imedos,GmbH, Jena) of 
diabetic patients revealed an increase in venous oxygen saturation in patients with diabetic 
retinopathy, which was in correlation with the severity of the retinopathy (Hammer, et al., 
2009). This implies reduced oxygen release to the tissue and tissue hypoxia which was 
attributed to either capillary closure and formation of arterio-venous shunt vessels or 
disturbance of vascular auto-regulation. 
4. Functional assessment of visual tests and ERG  
Retinal reflectance changes in response to photic stimulation carry information about 
metabolic processes underlying light responses in the retina. High-resolution, contrast 
agent-free optical imaging based on intrinsic signals in vivo has significantly contributed to 
understanding of the functional architecture of the neocortex (Grinvald et al., 1986). It 
reveals activity dependent changes in light reflectance, recorded using a digital camera with 
high spatial and temporal resolution. Such functional signals are usually small, originating 
from activity-dependent metabolic, hemodynamic, and fast and slow light-scattering 
changes (Frostig, et al., 1990, Malonek & Grinvald, 1996). 
The RFI is capable of imaging outside the absorption range of photoreceptors under near-
infrared light (750–840 nm), and can be used to optically monitor retinal activity in response 
to a well-defined visual stimulus (562 ±20 nm). The difference between the poststimulated 
and prestimulated images is used to determine the metabolic state of the retinal 
compartments. Change in light reflectance in response to a visual stimulus flashing were 
recorded in the cat retina (Izhaky et al., 2009). Similar experiments conducted on cats, 
monkeys, and humans have provided functional maps resulting from photic pattern 
activation(Abramoff et al., 2006, Hanazono, et al., 2008, Hanazono et al., 2007, Srinivasan, et 
al., 2009). 
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Electrophysiological studies of visual function in patients with diabetes mellitus 
demonstrate that functional alterations in the middle and inner retinal layers are present 
even prior to the development of clinical retinopathy (Bresnick & Palta, 1987, Tzekov & 
Arden, 1999, Zaharia, et al., 1987). Therefore, the diabetes induces changes in vision function 
may be not only secondary to vascular damage but also to neurosensory abmormality 
(Shirao & Kawasaki, 1998). Once diabetic retinopathy develops, additional 
electroretinogram (ERG) parameters are altered suggesting that photoreceptor abnormalities 
also occur. The changes are more pronounced compared to preretinopathy stage and there is 
a significant correlation between retinopathy severity and the magnitude of the functional 
loss (Holopigian, et al., 1992, van der Torren & Mulder, 1993, Weiner, et al., 1997). Multifocal 
ERG (mfERG), which maps local function, are abnormal in eyes of diabetic subjects without 
retinopathy and, to a greater degree, in eyes with mild or moderate NPDR. Moreover, 
abnormal mfERG implicit times are predictive of the development of new diabetic 
retinopathy over one and two years and are spatially associated with the retinopathy 
(Bearse, et al., 2006).  
5. Conclusions  
This chapter discuss the functional effect of diabetes mellitus on the retina. Retinal blood 
flow velocity measurements using the retinal function imager (RFI), discovered abnormal 
results in patients with various stages of diabetic-related ophthalmic condition. The result 
shows a significant decrease in arterial and venous velocity of patients with diabetic 
retinopathy and increase in diabetic patients with apparently normal retina compared to 
normals. The velocity correlation to blood pressure and heart rate was partially lost in the 
diabetic population either with or without retinopathy. The same technology was used to 
visualize capillary details without injecting contrast agents. Various vascular abnormalities 
like shunts and vascular loops were shown. In addition, examples of enlarged avascular 
zones in the fovea and ischemic retinal areas were presented. Multi-spectral imaging with 
the RFI was used to create qualitative oxymetry maps. Oxymetry measurement discovered 
increase in venous oxygen saturation. Imaging and analysis of changes in retinal reflectance 
in response to photic stimulation provides important information about retinal 
functionality. Electrophysiological alternations are present in early diabetes prior to the 
appearance of overt diabetic retinopathy.  
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